Product
Supplier
Encyclopedia
Inquiry
Rapamycin (cas:53123-88-9) buy - large image1
Rapamycin (cas:53123-88-9) buy - image1

Rapamycin (cas:53123-88-9)

29 Inquiries

Unit Price:

$4000/KG FOB

Get Latest Price
CAS No.:

53123-88-9

Port:

SHANGHAI

Packaging:

25kg/drum

Price valid (until):

2026-10-29

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Rapamycin (RAPA) is a new type of macrolide immunosuppressant. It is a white crystalline solid with a melting point of 183-185°C, lipophilic, soluble in organic solvents such as methanol, ethanol, acetone, and chloroform, very slightly soluble in water, and almost insoluble in ether. It was developed as early as the 1970s, initially used as a low-toxicity antifungal drug. In 1977, it was found to have immunosuppressive effects, and in 1989, RAPA began to be trialed as a new drug for the treatment of organ transplant rejection. Animal experiments and clinical applications have shown that it is an effective, low-toxicity, non-nephrotoxic immunosuppressant. It is now commonly used as a maintenance drug to preserve the immune function of transplanted organs (especially kidney transplants) to mitigate immune rejection after organ transplantation. However, scientists have recently discovered another use: it can be used to treat Alzheimer’s disease (senile dementia). What has piqued their interest is that the main component of rapamycin is also found in bacterial products from the isolated soils of Easter Island. Recent experiments have shown that administering this substance to experimental mice can restore memory deficits.

    Basic Info
    Product Name:

    Rapamycin

    Other Name:

    Rapamycin;23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rapamycin deriv.;Antibiotic AY 22989;[3S-[3R*[S*(1R*,3S*,4S*)],6S*,7E,9S*,10S*,12S*,14R*,15E,17E,19E,21R*,23R*,26S*,27S*,34aR*]]-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone;23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-,[3S-[3R*[S*(1R*,3S*,4S*)],6S*,7E,9S*,10S*,12S*,14R*,15E,17E,19E,21R*,23R*,26S*,27S*,34aR*]]-;(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone;AY 22989;(-)-Rapamycin;Sirolimus;SIIA 9268A;Rapamune;Rapammune;RPM;NSC 226080;RAPA;Wy 090217;Cypher;Nab rapamycin;Supralimus;14S-Rapamycin;Cypher Bx Velocity;PNP-sirolimus;DE 109;MS-RO01;MS-RO02;MS-RO03;Perceiva;Rapamysin;SVP-R;1179372-35-0;1189166-54-8;1233221-34-5;1353039-01-6

    CAS No.:

    53123-88-9

    Molecular Formula:

    C51H79NO13

    InChIKeys:

    InChIKey=QFJCIRLUMZQUOT-HPLJOQBZSA-N

    Molecular Weight:

    914.18

    Exact Mass:

    914.17

    EC Number:

    262-640-9

    HScode:

    2942000000

    Characteristics
    PSA:

    195

    XLogP3:

    6

    Appearance:

    yellow solid

    Density:

    1.2±0.1 g/cm3

    Melting Point:

    183-185 °C

    Boiling Point:

    973°C at 760 mmHg

    Flash Point:

    87 °C

    Refractive Index:

    1.551

    Water Solubility:

    soluble in DMSO at 50mg/ml or methanol at 25mg/ml. soluble in alcohol, dimethyl sulfoxide and dimethyl formamide. Insoluble in water.ethanol: soluble 2 MM

    Storage Conditions:

    -20°C

    Vapor Pressure:

    0.56 hPa ( 20 °C)

    Toxicity:

    LD50 in mice (mg/kg): 600 i.p.; >2,500 orally (Vézina)

    Specific rotation:

    D25 -58.2° (methanol)

    Hazard Identification

    Classification of the substance or mixture

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H351 Suspected of causing cancer

    H361 Suspected of damaging fertility or the unborn child

    H372 Causes damage to organs through prolonged or repeated exposure

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP

    Location:

    1613 Guangyin Building,No.42 E.Fengqi Road,Hangzhou,310012 China.

    Payment Terms:

    TT against copy of documents,L/C

    Average lead Time:

    7

    Total Annual Revenue:

    $25 million-$50 million

    Total Employees:

    11-50

    Year of Establishment:

    2011

    Dawn Ray is a R&D and process improvement company,which is located in Hangzhou, Zhejiang province,China.We are dealing in multi-application of pharmaceuticals(APIs),antibiotics,food additives,peptides and plant extracts.

    Dawn Ray has a wide range of products from milligram up to thousands of kilogram quantities.We are also increasing our breed all the time.Our products have been exported all over the world and have a good reputation.

    Dawn Ray promises that we can offer you qualified products and excellent service in good prices.Our aim is "Best goods,best service".We sincerely invite customers from all over the world to visit our company,establish business relations and both get win.

    Process Capacity: Synthetic,Ferment,extract

    After-sale Service:24 hours on skype for business

  • Inquiry History
    29 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Supply Medical Grade High Purity Rapamycin Powder CAS 53123-88-9 Rapamycin

    100 G Aug 16, 2023
    United States

    Raw Pharmaceutical Grade Material Rapamycin Powder CAS 53123-88-9 with High Purity

    100 G Jul 6, 2023
    Hungary

    Raw Pharmaceutical Grade Material Rapamycin Powder CAS 53123-88-9 with High Purity

    100 G Nov 20, 2023
    India

    Raw Pharmaceutical Grade Material Rapamycin Powder CAS 53123-88-9 with High Purity

    1000 MT Nov 18, 2023
    Germany

    Raw Pharmaceutical Grade Material Rapamycin Powder CAS 53123-88-9 with High Purity

    100 G Sep 7, 2023
    United States

    TNJONE High quality GMP Certificated 99% Purity Sirolimus Rapamycin 53123-88-9 in Stock

    1 G Jan 1, 2025
    United States

    Rapamycin Powder

    2 KG Aug 25, 2023
    Paraguay

    Rapamycin Sirolimus Powder

    1 G Feb 21, 2024
    India

    Rapamycin

    1 MT Feb 12, 2026
    India

    Rapamycin

    1.00 KG Jan 26, 2024
    United States

    Rapamycin

    50 MG Apr 17, 2026
    United States

    rapamycin

    100 G Sep 27, 2025
    Philippines

    Rapamycin

    5 G Feb 10, 2025
    Australia

    Rapamycin

    99 KG Nov 3, 2024
    United States

    Rapamycin

    10 MT May 22, 2024
    Canada

    Rapamycin

    1 KG Jan 24, 2025
    United States

    Rapamycin

    1 KG Nov 27, 2024
    United States

    rapamycin

    1 G Jul 12, 2024
    India

    Rapamycin

    1 KG Jun 28, 2024
    United States

    Rapamycin

    1 KG Apr 14, 2025
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.